|
Legfrissebb hozzászólások (1643 - 1652) (Témakör: Aktuális drogtémák)
| | | | | | | | | | tester: A MAPS megnyerte a versenyt! :) Most jött mélben:
"Due to the efforts of 603 MAPS supporters who submitted reviews of MAPS between June 1 and June 30, 2010, we won the Guidestar/Great Nonprofits Health Campaign 2010! We will receive a prize of $5000 along with increased credibility and visibility." |
| | | | |
| | | | | | | | | | Válasz a kérdésre: A feltöltő italába dobnék bélyeget. :D |
| | | | |
| | | | | | | | | | "LSD és a többi "laza" "partydrog" akkora kárt csinál az emberekbe, hogy nem ereszthető vissza a társadalomba!"
Nehéz elhinni, hogy ezek az emberek nem veterán trollok.
|
| | | | |
| | | | | | | | | | Írj pár sort a MAPS-ról, hogy megnyerhessék az 5000 dollárt! Az nyer, akiről a legtöbb review-t írják, és már csak egy nap van hátra. Ne felejtsd el kijelölni ennél a kérdésnél: "Should this review be counted for a specific campaign?" A "health awards"-ot
"If you haven't yet written a review, there is still time for you to write a review right now to insure that we stay in the lead!
Since I sent you this email yesterday over 200 supporters have written reviews in the Guidestar contest for $5000. We've doubled our number of reviews in one day and are still in first place with just one day to go. But the organization in second place is still accumulating reviews and I want to insure that we continue to win.
The contest ends tomorrow Wednesday June 30 at 11:59PM, and with just a few minutes of your help we can win.
Thank you,
Rick
P.S. I returned home Sunday night from conferences in Switzerland and Russia, where MAPS researchers and I presented information about our psychedelic research projects. We're gathering momentum all over the world. With just a few minutes of your help, together we can win the Guidestar contest and demonstrate the strength and depth of our psychedelic research community."
|
| | | | |
| | | | | | | | | | Hát igen, szándéktól függően elég sok lehetőség adott! Már csak élni kell vele. |
| | | | |
|